by Ted Agres
NEWS ANALYSIS	Conflict probe expands to FDA Email: Ted Agres - tedagres@lycos.com News from The Scientist 2004, 5(1):20040519-03 Published   19 May 2004

WASHINGTON, DC—The US Food and Drug Administration (FDA) will conduct a “comprehensive review” of all outside consulting agreements its employees have with pharmaceutical and biotech companies to make sure the arrangements are legal, acting FDA commissioner Lester M. Crawford announced yesterday (May 18).

(continued >>)

To continue reading this full article, you must be a subscriber to The Scientist.

You are only a few minutes away from unlimited access.

If you already have an online subscription, please Log-In Now.
New to The Scientist? Register to get access to a selection of our content, interactive features and useful tools free without a subscription.

Subscribe to The Scientist to get unlimited access to our premium content

Get unlimited access to this article and over 20 years of The Scientist archives. You won’t miss a word – all for as little as $4.95.  Subscribe now.

The Scientist offers site licenses to institutions and organizations. Recommend us to your librarian and get online access through your place or work or study.